Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule
Image
Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.
Nasdaq closes compliance matter after ADS price clears threshold for 19 sessions
The closing bid price of Scinai's ADSs met or exceeded $1.00 per share from August 21, 2026 through September 17, 2026, satisfying Nasdaq Listing Rule 5550(a)(2). Nasdaq had first flagged the deficiency on March 12, 2026, after the ADSs failed to maintain the $1.00 minimum over the prior 30 consecutive business days.
CEO says resolution shifts focus to CDMO commercial execution
"Receiving Nasdaq's confirmation closes an important compliance matter for Scinai,